ヨーロッパ全域の腫瘍学分野における教育技術の現在の使用:横断的研究
Jana Steinbacher1, Taibe Kulaksız2, Marco Kalz3
1Institut für Bildungsanalysen Baden-Württemberg, Stuttgart, Germany.
まとめ
腫瘍学訓練のデジタル教育はヨーロッパ各地に異なります. シンクロン・ブレンド・ラーニングの普及率は高いが,VRのような非シンクロン・新興技術は採用率が低く,地域や職業の格差が顕著だ.
科学分野:
- 医学教育
- デジタル・ヘルス
- 腫瘍学
背景:
- デジタル教育は がん治療の訓練においてますます重要になってきています
- この研究は,ヨーロッパの腫瘍学における現在の教育技術の使用を調査しています.
研究 の 目的:
- ヨーロッパ全域での腫瘍学訓練における教育技術の採用と慣れ親しさを調査する.
- デジタル・ラーニング・ツールの利用における地域的および専門的な違いを特定する.
主な方法:
- 横断的な研究デザイン
- ヨーロッパ全域の腫瘍学学習者や教育者の便利なサンプリング
- ライム・サーベイによるオンラインデータ収集
主要な成果:
- シンクロンとブレンドラーニングは最もよく知られ,アシンクロンとハイブリッド形式はあまり知られていません.
- 仮想現実やシミュレーションは あまり使われていません
- 地域 (北欧,中欧,南欧) と専門分野 (がん看護師と臨床腫瘍学者) の技術採用と慣れ親しさに大きな格差がある.
結論:
- 学習目標と参加者の多様な経験とニーズを一致させることは,多学科的な腫瘍学研修において極めて重要です.
- 地域/職業の格差を克服するには,デジタルインフラ,アクセシビリティ,制度的支援の改善に向けた取り組みが必要です.
- これらの発見を検証するために,さらなる説明研究が推奨されます.
さらに関連する動画
09:55Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
Published on: September 28, 2022
1.7K
05:33Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation
Published on: September 6, 2024
1.7K
関連する概念動画
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Cancer
49.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.5K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
